When SSRIs are Not Enough: Targeting Residual Symptoms in Major Depressive Disorder

When SSRIs are Not Enough: Targeting Residual Symptoms in Major Depressive Disorder is organized by Pri-Med.

Release Date: 12/06/2024
Expiration Date: 12/06/2025

Description:
In this podcast, expert faculty will discuss how the heterogeneity of major depressive disorder (MDD) symptoms, the frequency of residual symptoms, and the common occurrence of treatment-resistant depression (TRD) indicate a pathophysiology that is complex and multifactorial. The faculty will provide an overview of the current understanding of MDD pathophysiology and discuss how current standard-of-care treatments often fail to comprehensively target these mechanisms, emphasizing how future treatment developments can focus on under-addressed pathophysiological mechanisms, paving the way for personalized MDD treatments that target individual symptom profiles.

Learning Objectives:

• Examine the correlation between unresolved, residual symptoms of major depressive disorder (MDD) and underlying pathophysiology not addressed with current standard-of-care treatments
• Explore the neurobiology underpinning anhedonia in MDD and novel agents designed to address it (additional learning objective for accreditation purposes)
• Explore the neurobiology underpinning insomnia in MDD and novel agents designed to address it (additional learning objective for accreditation purposes)

Topics

• Depression
• Psychiatry & Behavioral Health
• Sleep Medicine